132 related articles for article (PubMed ID: 31066170)
1. c-MYB- and PGC1a-dependent metabolic switch induced by MYBBP1A loss in renal cancer.
Felipe-Abrio B; Verdugo-Sivianes EM; Carnero A
Mol Oncol; 2019 Jul; 13(7):1519-1533. PubMed ID: 31066170
[TBL] [Abstract][Full Text] [Related]
2. The Tumor Suppressor Roles of MYBBP1A, a Major Contributor to Metabolism Plasticity and Stemness.
Felipe-Abrio B; Carnero A
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31968688
[TBL] [Abstract][Full Text] [Related]
3. Loss of MYBBP1A Induces Cancer Stem Cell Activity in Renal Cancer.
Felipe-Abrio B; Verdugo-Sivianes EM; Sáez C; Carnero A
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781655
[TBL] [Abstract][Full Text] [Related]
4. PGC1α suppresses kidney cancer progression by inhibiting collagen-induced SNAIL expression.
Nam H; Kundu A; Brinkley GJ; Chandrashekar DS; Kirkman RL; Chakravarthi BVSK; Orlandella RM; Norian LA; Sonpavde G; Ghatalia P; Fei F; Wei S; Varambally S; Sudarshan S
Matrix Biol; 2020 Jul; 89():43-58. PubMed ID: 31982456
[TBL] [Abstract][Full Text] [Related]
5. MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis.
Akaogi K; Ono W; Hayashi Y; Kishimoto H; Yanagisawa J
BMC Cancer; 2013 Feb; 13():65. PubMed ID: 23388179
[TBL] [Abstract][Full Text] [Related]
6. Myb-binding protein 1A (MYBBP1A) is essential for early embryonic development, controls cell cycle and mitosis, and acts as a tumor suppressor.
Mori S; Bernardi R; Laurent A; Resnati M; Crippa A; Gabrieli A; Keough R; Gonda TJ; Blasi F
PLoS One; 2012; 7(10):e39723. PubMed ID: 23056166
[TBL] [Abstract][Full Text] [Related]
7. Grifolin inhibits tumor cells adhesion and migration via suppressing interplay between PGC1α and Fra-1 / LSF- MMP2 / CD44 axes.
Luo X; Li N; Zhong J; Tan Z; Liu Y; Dong X; Cheng C; Xu Z; Li H; Yang L; Tang M; Weng X; Yi W; Liu J; Cao Y
Oncotarget; 2016 Oct; 7(42):68708-68720. PubMed ID: 27626695
[TBL] [Abstract][Full Text] [Related]
8. A PGC1α-mediated transcriptional axis suppresses melanoma metastasis.
Luo C; Lim JH; Lee Y; Granter SR; Thomas A; Vazquez F; Widlund HR; Puigserver P
Nature; 2016 Sep; 537(7620):422-426. PubMed ID: 27580028
[TBL] [Abstract][Full Text] [Related]
9. Regulation and function of Myb-binding protein 1A (MYBBP1A) in cellular senescence and pathogenesis of head and neck cancer.
George B; Horn D; Bayo P; Zaoui K; Flechtenmacher C; Grabe N; Plinkert P; Krizhanovsky V; Hess J
Cancer Lett; 2015 Mar; 358(2):191-199. PubMed ID: 25543088
[TBL] [Abstract][Full Text] [Related]
10. PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness.
Kaminski L; Torrino S; Dufies M; Djabari Z; Haider R; Roustan FR; Jaune E; Laurent K; Nottet N; Michiels JF; Gesson M; Rocchi S; Mazure NM; Durand M; Tanti JF; Ambrosetti D; Clavel S; Ben-Sahra I; Bost F
Cancer Res; 2019 Jul; 79(13):3268-3280. PubMed ID: 31064849
[TBL] [Abstract][Full Text] [Related]
11. ALY is a common coactivator of RUNX1 and c-Myb on the type B leukemogenic virus enhancer.
Mertz JA; Kobayashi R; Dudley JP
J Virol; 2007 Apr; 81(7):3503-13. PubMed ID: 17229714
[TBL] [Abstract][Full Text] [Related]
12. PGC1α promotes cholangiocarcinoma metastasis by upregulating PDHA1 and MPC1 expression to reverse the Warburg effect.
Dan Li ; Wang C; Ma P; Yu Q; Gu M; Dong L; Jiang W; Pan S; Xie C; Han J; Lan Y; Sun J; Sheng P; Liu K; Wu Y; Liu L; Ma Y; Jiang H
Cell Death Dis; 2018 May; 9(5):466. PubMed ID: 29700317
[TBL] [Abstract][Full Text] [Related]
13. The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications.
Tan Z; Luo X; Xiao L; Tang M; Bode AM; Dong Z; Cao Y
Mol Cancer Ther; 2016 May; 15(5):774-82. PubMed ID: 27197257
[TBL] [Abstract][Full Text] [Related]
14. Myb protein specificity: evidence of a context-specific transcription factor code.
Ness SA
Blood Cells Mol Dis; 2003; 31(2):192-200. PubMed ID: 12972026
[TBL] [Abstract][Full Text] [Related]
15. Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress.
Chen Y; Zhang Z; Yang K; Du J; Xu Y; Liu S
Oncogene; 2015 Jul; 34(29):3839-47. PubMed ID: 25284586
[TBL] [Abstract][Full Text] [Related]
16. Targeting mitochondrial oxidative metabolism in melanoma causes metabolic compensation through glucose and glutamine utilization.
Lim JH; Luo C; Vazquez F; Puigserver P
Cancer Res; 2014 Jul; 74(13):3535-45. PubMed ID: 24812272
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of PGC‑1α enhances cell proliferation and tumorigenesis of HEK293 cells through the upregulation of Sp1 and Acyl-CoA binding protein.
Shin SW; Yun SH; Park ES; Jeong JS; Kwak JY; Park JI
Int J Oncol; 2015 Mar; 46(3):1328-42. PubMed ID: 25585584
[TBL] [Abstract][Full Text] [Related]
18. H3K27me3-mediated PGC1α gene silencing promotes melanoma invasion through WNT5A and YAP.
Luo C; Balsa E; Perry EA; Liang J; Tavares CD; Vazquez F; Widlund HR; Puigserver P
J Clin Invest; 2020 Feb; 130(2):853-862. PubMed ID: 31929186
[TBL] [Abstract][Full Text] [Related]
19. c-Myb protein interacts with Rcd-1, a component of the CCR4 transcription mediator complex.
Haas M; Siegert M; Schürmann A; Sodeik B; Wolfes H
Biochemistry; 2004 Jun; 43(25):8152-9. PubMed ID: 15209511
[TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes is associated with decreased PGC1α expression in epicardial adipose tissue of patients with coronary artery disease.
Moreno-Santos I; Pérez-Belmonte LM; Macías-González M; Mataró MJ; Castellano D; López-Garrido M; Porras-Martín C; Sánchez-Fernández PL; Gómez-Doblas JJ; Cardona F; de Teresa-Galván E; Jiménez-Navarro M
J Transl Med; 2016 Aug; 14(1):243. PubMed ID: 27542888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
